by pachaary@mmsholdings.com | Apr 16, 2020 | News
FORMER GILEAD SCIENCES HEAD OF CLINICAL TRIAL DISCLOSURE AND DATA TRANSPARENCY JOINS MMS AND TRIALASSURE AS DIRECTOR OF GLOBAL TRANSPARENCY STRATEGY AND COMPLIANCE by Donald McLean, MBA,Posted on 4/16/2020 Kelly Vaillant CANTON, Mich. (April 16, 2020) – MMS Holdings...
by pachaary@mmsholdings.com | Apr 10, 2020 | News
TRIALASSURE TRANSPARENCY SUITE WINS DATA SOLUTION OF THE YEAR—HEALTHCARE IN THE 2020 DATA BREAKTHROUGH AWARDS by Donald McLean, MBA,Posted on 4/10/2020 CANTON, Mich. (April 10, 2020) – TrialAssure® – the technology arm of MMS and leading, global software company...
by pachaary@mmsholdings.com | Apr 7, 2020 | News
As Universities and Academic Institutions Face Unique Challenges in Reporting Clinical Trials, TrialAssure Responds by Offering Free Clinical Trial Transparency Tool by Donald McLean, MBA,Posted on 4/7/2020 CANTON, Mich. (April 7, 2020) – TrialAssure® – a leading,...
by pachaary@mmsholdings.com | Mar 12, 2020 | News
Committed to the health of your projects during COVID-19 by Staff writer,Posted on 3/12/2020 I would like to take a moment and share our commitment to the highest levels of health and improving lives worldwide, amidst the outbreak of COVID-19. The health of our staff...
by pachaary@mmsholdings.com | Nov 7, 2019 | News
TrialAssure Launches First-in-Class Document Anonymization Tool Using Machine Learning and Artificial Intelligence to Protect Patient Data by Donald McLean, MBA,Posted on 11/7/2019 Canton, Mich. (November 7, 2019) – TrialAssure® – a leading, global software company...
